Table 1.
Name | Primer sequence (5′-3′) |
---|---|
TRIM22-F | TTTAAGCTTATGGATTTCTCAGTAAAGGTAGACATA |
TRIM22-R | TTTCTCGAGGGAGCTCGGTGGGCACACAGTCATGGG |
ΔRING-F | TTTAAGCTTCAGACCAGATTCCAGCCTGGGAACCTC |
SPRY-F | TTTAAGCTTAAGAAGCCAAAATCTGTTTCCAAGAAA |
ΔSPRY-R | TTTCTCGAGGTACTGGACATCTGTCAGCTCTTTAAG |
ΔNLS-F | GAGTGAAAGCTGGACATTGAGTGTATTCCGAGTACCAG |
ΔNLS-R | CTGGTACTCGGAATACACTCAATGTCCAGCTTTCACTC |
ORF7-F | TTTGAATTCATGCCAAATAACAACGGCAAGCAGC |
ORF7-R | TTTAGATCTTCATGTTGGGGGTGATGCTGTGGCG |
K10-4A-F1 | AGCAAGCGGCAGCGGCGGGGAATGGCCAGCCAGTCGA |
K10-4A-F2 | ATAACAACGGCAAGCAGCAAGCGGCAGCGGCGGGGAATG |
C23A-F1 | AGCCAGTCGATCAGCTGGCCCAAATGCTGGGTAAGATCA |
C23A-F2 | AAAGAAAAAGAAGGGGAATGGCCAGCCAGTCGATCAGCTGG |
C23A-F3 | ATAACAACGGCAAGCAGCAAAAGAAAAAGAAGGGGAA |
Q32-4A-F | CATCGCCGCAGCAGCCGCGTCCAGAGGCAAGGGACCG |
Q32-4A-R | CTCTGGACGCGGCTGCTGCGGCGATGATCTTACCCAG |
K43-2A-F | ACCGGGGGCGGCAAATAGGAAGAAAAACCCG |
K43-2A-R | CTTCCTATTTGCCGCCCCCGGTCCCTTGCCTCTG |
P50-3A-F | CGGAGAAGGCCCATTTCGCTCTAGCGACTGAAGATGACG |
P50-3A-R | GCGAAATGGGCCTTCTCCGCGTTTTTCTTCCTATTTTTC |
The restriction enzyme sites used for cloning are underlined in italics. Locations of mutations are underlined